Development of Inhalable Dry-emulsion Formulation of Cyclosporine A with Improved Anti-inflammatory Effects and Reduced Systemic Exposure
スポンサーリンク
概要
- 論文の詳細を見る
- 2013-03-01
著者
-
Sato Hideyuki
School Of Pharmaceutical Sciences University Of Shizuoka
-
Yamada Shizuo
School Of Pharmaceutical Science University Of Shizuoka
-
AOKI Yosuke
School of Pharmaceutical Science, University of Shizuoka
-
Kojo Yoshiki
School Of Pharmaceutical Science University Of Shizuoka
-
Mizumoto Takahiro
Ils Inc.
-
Ogawa Kumiko
School Of Pharmaceutical Science University Of Shizuoka
-
ONOUE Satomi
School of Pharm. Sci., University of Shizuoka
-
OGAWA Kumiko
School of Pharmaceutical sciences, University of Shizuoka
-
KATO Masashi
School of Pharmaceutical sciences, University of Shizuoka
関連論文
- Monospecific Antipeptide Antibodies Against Human Hepatic UDP-Glucuronosyltransferase 1A Subfamily (UGT1A) Isoforms
- Species difference among mice, hamsters, rats, and guinea pigs in phenobarbital-induced alteration of serum thyroxine level(Proceedings of the 32nd Annual Meeting)
- Mechanistic study for the decrease in serum thyroxine level in PCB-treated mice(Proceedings of the 32nd Annual Meeting)
- Blood-Brain Permeability of [^3H]-(3-methyl-His^2) Thyrotropin-releasing Hormone (MeTRH) in Mice : Effects of TRH and its Analogues
- Effects of Methylsulfonyl Metabolites of PCBs Accumulated in Tissues of Mammals on Activities of Hepatic Microsomal Drug-Metabolizing Enzymes in Rats (Proceedings of the 19th Symposium on Toxicology and Environmental Health)
- Effects of Sulfur-Containing Metabolites of Hexachlorobenzene on the Heme Metabolic Enzymes in Rat Liver
- Development of Novel Vasoactive Intestinal Peptide Derivatives with Improved Stability : Physicochemical and Pharmacological Characterization
- Protective Effects of PACAP and Its Analogs on Apoptotic Death of Rat Pancreatic β Cells
- Inhalable powder formulation of vasoactive intestinal peptide derivatives, [R^, L^]-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats
- Development of glucagon-loaded PLGA nanospheres for inhalation therapy with improved pharmacokinetics and pharmacodynamics
- Inhalable powder formulation of stabilized vasoactive intestinal peptide derivative (IK312548)
- New PACAP38 Analogue with Improved Stability : Physicochemical and Biochemical Characterization
- Development of Vasoactive Intestinal Peptide Derivative-Loaded PLGA Nanospheres with Improved Duration of Action
- 3,3',4,4'-Tetrachlorobiphenyl-Mediated Decrease of Serum Thyroxine Level in C57BL/6 and DBA/2 Mice Occurs Mainly through Enhanced Accumulation of Thyroxine in the Liver
- Development of Inhalable Dry-emulsion Formulation of Cyclosporine A with Improved Anti-inflammatory Effects and Reduced Systemic Exposure